Multimodal Imaging of Pancreatic Ductal Adenocarcinoma Using Multifunctional Nanoparticles as Contrast Agents

被引：0

作者：

Zhao, Ying ^{[1
,2
]}

Ye, Fei ^{[1
,3
]}

Brismar, Torkel B. ^{[4
]}

Li, Xuan ^{[5
]}

He, Rui ^{[1
,2
]}

Heuchel, Rainer ^{[5
]}

El-Sayed, Ramy ^{[1
]}

Feliu, Neus ^{[1
,6
]}

Zheng, Wenyi ^{[1
,2
]}

Oerther, Sandra ^{[1
,2
]}

Dutta, Joydeep ^{[3
]}

Parak, Wolfgang J. ^{[6
]}

Muhammed, Mamoun ^{[3
,7
]}

Hassan, Moustapha ^{[1
,2
,7
]}

机构：

[1] Division of Experimental Cancer Medicine, Department of Laboratory Medicine (LABMED), Karolinska Institutet, Stockholm,SE-141 86, Sweden

[2] Clinical Research Center, Center for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital-Huddinge, Stockholm,SE-141 86, Sweden

[3] KTH Royal Institute of Technology, Stockholm,SE-100 44, Sweden

[4] Division of Medical Imaging and Technology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm,SE-141 86, Sweden

[5] Pancreatic Cancer Research Laboratory, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm,SE-141 86, Sweden

[6] Center for Hybrid Nanostructures (CHyN), University of Hamburg, Hamburg,22607, Germany

[7] Institute of Graduate Studies and Research (IGSR), Alexandria University, Alexandria,21526, Egypt

来源：

ACS Applied Materials and Interfaces | 2020年 / 12卷 / 48期

关键词：

Late diagnosis and refractory behavior toward current treatment protocols make pancreatic ductal adenocarcinoma (PDAC) one of the most difficult cancer forms to treat. The imaging-based approach plays an important role to identify potentially curable PDAC patients in high-risk groups at the early stage. In the present study; we developed a core-shell structured gold nanorod (AuNR) as a contrast agent for multimodal imaging and investigated its application for PDAC diagnosis. The composite nanoparticles composed of a AuNR core inside a layer of mesoporous silica that was then coated with a gadolinium oxide carbonate shell (AuNR-SiO2-Gd) are designed to be used in magnetic resonance imaging (MRI); X-ray computed tomography (CT); and photoacoustic imaging (PAI). A phantom study with the AuNR-SiO2-Gd NPs demonstrated higher MRI contrast compared to Gadovist and higher X-ray attenuation than Visipaque. A strong; stable; and broad wavelength range signal with a peak at 800 nm was observed in PAI. The AuNR-SiO2-Gd NPs showed significant contrast enhancement under PAI/MRI/CT in both the liver and spleen of control mice after intravenous administration. The utility in PDAC was studied in a genetically engineered mouse model carrying Kras and p53 mutations; which develops spontaneous tumors and keeps the desmoplasia and hypovascularity feature of PDAC in patients. The AuNR-SiO2-Gd NPs were highly accumulated in the surrounding soft tissues but were sparsely distributed throughout the tumor due to dense stroma infiltration and poor tumor vascularization. Hence; a negative contrast within the tumor area in CT/PAI and a positive contrast in MRI were observed. In conclusion; AuNR-SiO2-Gd NPs have good potential to be developed as a multimodal contrast agent for PDAC; which might improve early diagnosis and benefit the clinical outcome for PDAC patients. ©;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：53665 / 53681

共 50 条

[1] Multimodal Imaging of Pancreatic Ductal Adenocarcinoma Using Multifunctional Nanoparticles as Contrast Agents
Zhao, Ying
Ye, Fei
Brismar, Torkel B.
Li, Xuan
He, Rui
Heuchel, Rainer
El-Sayed, Ramy
Feliu, Neus
Zheng, Wenyi
Oerther, Sandra
Dutta, Joydeep
Parak, Wolfgang J.
Muhammed, Mamoun
Hassan, Moustapha
ACS APPLIED MATERIALS & INTERFACES, 2020, 12 (48) : 53665 - 53681
[2] Multifunctional contrast agents for targeted and multimodal molecular imaging
Tu, Chuqiao
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[3] Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
Kelly, Kimberly A.
Bardeesy, Nabeel
Anbazhagan, Rajesh
Gurumurthy, Sushma
Berger, Justin
Alencar, Herlen
DePinho, Ronald A.
Mahmood, Umar
Weissleder, Ralph
PLOS MEDICINE, 2008, 5 (04) : 657 - 668
[4] Multimodal treatment of resectable pancreatic ductal adenocarcinoma
Silvestris, Nicola
Brunetti, Oronzo
Vasile, Enrico
Cellini, Francesco
Cataldo, Ivana
Pusceddu, Valeria
Cattaneo, Monica
Partelli, Stefano
Scartozzi, Mario
Aprile, Giuseppe
Gardini, Andrea Casadei
Morganti, Alessio Giuseppe
Valentini, Vincenzo
Scarpa, Aldo
Falconi, Massimo
Calabrese, Angela
Lorusso, Vito
Reni, Michele
Cascinu, Stefano
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 111 : 152 - 165
[5] Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma
Silvestris, Nicola
Longo, Vito
Cellini, Francesco
Reni, Michele
Bittoni, Alessandro
Cataldo, Ivana
Partelli, Stefano
Falconi, Massimo
Scarpa, Aldo
Brunetti, Oronzo
Lorusso, Vito
Santini, Daniele
Morganti, Alessio
Valentini, Vincenzo
Cascinu, Stefano
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 98 : 309 - 324
[6] Nuclear-NIR multifunctional contrast agents for pancreatic cancer imaging
Choi, Hak Soo
Bao, Kai
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
[7] Imaging mimics of pancreatic ductal adenocarcinoma
Namita S. Gandhi
Myra K. Feldman
Ott Le
Gareth Morris-Stiff
Abdominal Radiology, 2018, 43 : 273 - 284
[8] Imaging mimics of pancreatic ductal adenocarcinoma
Gandhi, Namita S.
Feldman, Myra K.
Le, Ott
Morris-Stiff, Gareth
ABDOMINAL RADIOLOGY, 2018, 43 (02) : 273 - 284
[9] Imaging of small pancreatic ductal adenocarcinoma
Ariyama, J
Suyama, M
Satoh, K
Sai, J
PANCREAS, 1998, 16 (03) : 396 - 401
[10] Molecular imaging of pancreatic ductal adenocarcinoma
Huang, Wei
Huang, Gang
An, Shuxian
Liu, Jianjun
VIEW, 2023, 4 (05)

← 1 2 3 4 5 →